Companies / Lifeward Ltd.

Lifeward Ltd.

Nasdaq: LFWDCIK 1607962HUDSON, MA

Financials · FY2025

Revenue$22.03M
Net income$-19.91M
Total debt$394.0K
Cash$11.42M
Diluted EPS$-17.16
Shares outstanding2.8M

Ownership

2.8M shares outstanding · as of May 18, 2026
100.0%Public float
Ownership
Public float100.00%2,814,409

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Adar AlmogChief Financial Officer
——
Grant William MarkCEOPresident & CEO · Director
——
Kidron MiriamFormerDirector
——
Kidron NadavFormerDirector
——
Oramed Pharmaceuticals Inc.10% owner
——
Reznick YehudaFormerDirector
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 25, 2026Reznick Yehuda
Director
GrantOrdinary Shares, no par value per share$0+8K
7,657
0.27% of shares
low
Mar 25, 2026Kidron Nadav
Director
GrantOrdinary Shares, no par value per share$0+8K
7,657
0.27% of shares
low
Mar 25, 2026Kidron Miriam
Director
GrantOrdinary Shares, no par value per share$0+8K
7,657
0.27% of shares
low
Mar 25, 2026Grant William Mark
CEO
GrantOption (Right to Buy)—+173K
172,698
6.14% of shares
low
Mar 25, 2026Adar Almog
Executive
GrantOption (Right to Buy)—+40K
39,934
1.42% of shares
low